Dr. Margaret E Stone, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 2170 Maxham Meadow Way 4a, Woodstock, VT 05091 Phone: 802-457-4464 Fax: 802-457-4591 |
Dr. Margaret Nassym Janisse, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 217 Maxham Meadow Way # 10, Suite 104c, Woodstock, VT 05091 Phone: 802-457-1903 |
Dr. John David Laughlin, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 32 Pleasant St, Woodstock, VT 05091 Phone: 802-457-2922 Fax: 802-457-1835 |
Dr. Mark David Knott, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 32 Pleasant St, Woodstock, VT 05091 Phone: 802-457-2922 Fax: 802-457-1835 |
Whitam K. Vanmeter Jr., D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 32 Pleasant St, Woodstock, VT 05091 Phone: 802-457-3460 |
News Archive
Mennen Medical, a leading provider of patient monitors, cardiac catheterization and electrophysiology systems, announced today that the global growth consulting company Frost & Sullivan has awarded Mennen Medical the 2009 European Patient Monitoring Technology Leadership of the Year Award.
A home-based diet and exercise program reduced the rate of functional decline among older, overweight long-term survivors of colorectal, breast and prostate cancer, according to a study in the May 13 issue of JAMA, the Journal of the American Medical.
Health Diagnostic Laboratory, Inc. is taking the next step in its mission to detect, prevent and reverse major chronic disease such as heart disease and diabetes with the launch of My HDL Hub health centers. HDL, Inc.'s My HDL Hub is a place for individuals to receive comprehensive blood tests, gain lifestyle, nutrition and fitness guidance with the company's Clinical Health Consultants and relate to others in the community with common goals of becoming healthier.
Researchers at Mayo Clinic's campus in Florida have discovered a key gene that, when turned off, promotes the development of common kidney cancer. Their findings suggest that a combination of agents now being tested in other cancers may turn the gene back on, providing a much-needed therapy for the difficult-to-treat cancer.
› Verified 7 days ago